Ann: Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives, page-48

  1. 532 Posts.
    lightbulb Created with Sketch. 127
    Astounding value offered here at this SP, and that's only accounting for the approved treatment/application IMO.

    I need to spend more time reviewing the depth and entirety of the patent estate, possible treatment indications and possible addressable market sizes thereof, but I'm firmly convinced investment in MSB should be highly rewarding for people with the patience and conviction to hold + accumulate as a portion of their portfolio.

    Although existing holders might not like to see quoted paper value of their holdings decline further any broad market weakness due to macroeconomic events may offer an astounding value buying opportunity for those blessed with significant cash flow.

    GLTAH & IMO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.86
Change
0.065(3.62%)
Mkt cap ! $2.376B
Open High Low Value Volume
$1.83 $1.89 $1.83 $8.165M 4.404M

Buyers (Bids)

No. Vol. Price($)
2 6744 $1.86
 

Sellers (Offers)

Price($) Vol. No.
$1.86 5904 3
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.